Quality and Safety
Acting CMS leader Marilyn Tavenner pushes for better care, better health and lower costs in her speech at the Care Innovations Summit on Thursday.
New drugs in three multi-billion dollar categories will help pharmaceutical companies offset patent expirations and will ease pressure on credit rating outlooks, says a new report from Moody's Investors Service.
Recently, the Huron Consulting Group released its report, "Leading Through Transformation: Top Healthcare CEO's Perspectives on the Future of Healthcare." The report included insights from the Huron Healthcare CEO Forum and took a hard look at some of the top industry issues that will be plaguing CEOs in the year to come.
The Medical Group Management Association (MGMA) yesterday announced that medical practices found to be above average in its annual performance survey excelled in four distinct management categories.
India's largest drug manufacturer, Ranbaxy Laboratories and its U.S. subsidiary, Ranbaxy Inc., and the U.S. Justice Department, and U.S. Food and Drug Administration have reached an agreement over allegations that the company was selling potentially unsafe drugs in the United States.
The Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) is offering $14 million in grants to support research to build a scientific evidence base for effective public reporting.
HealthGrades, a provider of consumer healthcare information, today released a list of America's top cities for hospital care.
The Ohio Department of Public Health and the year-old Governor's Office of Health Transformation (OHT) announced Wednesday that the state will invest $1 million to help primary care practices transition to a patient-centered medical home model.
For the last five months, members of an independent organization established by the Affordable Care Act have been developing a national priorities agenda that may transform medical care and save healthcare dollars. The first draft of that agenda will become available for public comment beginning Monday.
Most of the Medicare fee-for-service demonstration projects launched in the past two decades using disease management and value-based payments have failed to reduce costs, says a report issued yesterday by the Congressional Budget Office.